# Risk Reduction in Coronary Heart Disease

> **NCT00679237** · NA · COMPLETED · sponsor: **Sorlandet Hospital HF** · enrollment: 1600 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **BEHAVIORAL:** smoking cessation
- **DRUG:** betablocker, diuretics, ACEI, ARB,
- **DRUG:** statins, ezetimibe
- **BEHAVIORAL:** training
- **BIOLOGICAL:** influenza vaccine
- **DRUG:** metformin, glimepiride, insulin
- **BEHAVIORAL:** weight reduction

## Key facts

- **NCT ID:** NCT00679237
- **Lead sponsor:** Sorlandet Hospital HF
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 1600 (ACTUAL)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679237, "Risk Reduction in Coronary Heart Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00679237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*